<DOC>
	<DOCNO>NCT00859352</DOCNO>
	<brief_summary>The primary objective study investigate exposure midazolam clinically significantly change 14 day exposure AZD1981 possible enzyme induction CYP3A .</brief_summary>
	<brief_title>AZD1981 Midazolam CYP4503A Induction Study</brief_title>
	<detailed_description />
	<mesh_term>Midazolam</mesh_term>
	<criteria>Provision inform consent prior study specific procedure Have body mass index 19 30 kg/m2 weigh least 50 kg 100 kg Be nonsmoker exsmoker stop smoke &gt; 6 month prior Visit 1 ( preentry ) Any clinically significant disease disorder , opinion investigator , may either put subject risk participation study , influence result study , subjectÂ´s ability participate Any clinically relevant abnormal finding phys.examination , clinical chemistry , haematology , urinalysis , vital sign , ECG baseline , opinion investigator , may put subject risk participation study</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2009</verification_date>
</DOC>